[HTML] springer.comFull View

[HTML][HTML] Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology

MI Fonseca, SO McGuire, SE Counts… - Journal of …, 2013 - Springer
Background Alzheimer's disease (AD) is a neurodegenerative dementia characterized by
the decline of cognition and the presence of neuropathological changes including neuronal …
被引用次数：54 相关文章
[HTML] nih.gov

[HTML][HTML] Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology

MI Fonseca, SO McGuire, SE Counts… - Journal of …, 2013 - ncbi.nlm.nih.gov
Background Alzheimer's disease (AD) is a neurodegenerative dementia characterized by
the decline of cognition and the presence of neuropathological changes including neuronal …
[PDF] academia.edu

[PDF][PDF] Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology

MI Fonseca, SO McGuire, SE Counts, AJ Tenner - 2013 - academia.edu
Background: Alzheimer's disease (AD) is a neurodegenerative dementia characterized by
the decline of cognition and the presence of neuropathological changes including neuronal …

Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology.

MI Fonseca, SO McGuire, SE Counts… - Journal of …, 2013 - search.ebscohost.com
Background: Alzheimer's disease (AD) is a neurodegenerative dementia characterized by
the decline of cognition and the presence of neuropathological changes including neuronal …

Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology

MI Fonseca, SO McGuire, SE Counts, AJ Tenner - 2013 - indigo.uic.edu
Background: Alzheimer's disease (AD) is a neurodegenerative dementia characterized by
the decline of cognition and the presence of neuropathological changes including neuronal …

Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology

MI Fonseca, SO McGuire, SE Counts… - Journal of …, 2013 - infona.pl
Background Alzheimer's disease (AD) is a neurodegenerative dementia characterized by
the decline of cognition and the presence of neuropathological changes including neuronal …
[HTML] biomedcentral.com

[HTML][HTML] Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology

MI Fonseca, SO McGuire… - Journal of …, 2013 - jneuroinflammation.biomedcentral …
Alzheimer's disease (AD) is a neurodegenerative dementia characterized by the decline of
cognition and the presence of neuropathological changes including neuronal loss …

Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology

MI Fonseca, SO McGuire, SE Counts… - Journal of …, 2013 - search.proquest.com
Background: Alzheimer's disease (AD) is a neurodegenerative dementia characterized by
the decline of cognition and the presence of neuropathological changes including neuronal …
[PDF] cyberleninka.org

[PDF][PDF] Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology

MI Fonseca, SO McGuire, SE Counts, AJ Tenner - 2013 - cyberleninka.org
Background: Alzheimer's disease (AD) is a neurodegenerative dementia characterized by
the decline of cognition and the presence of neuropathological changes including neuronal …

Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology.

MI Fonseca, SO McGuire, SE Counts… - Journal of …, 2013 - europepmc.org
Background Alzheimer's disease (AD) is a neurodegenerative dementia characterized by
the decline of cognition and the presence of neuropathological changes including neuronal …